Skip to content

Food is Medicine: Pilot Study

Food Is Medicine Shared Medical Appointments for Weight Management: A Pilot Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06797453
Enrollment
43
Registered
2025-01-28
Start date
2025-04-01
Completion date
2025-06-30
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight Loss

Keywords

Weight Management

Brief summary

The goal of this study is to determine whether shared medical visits also called group visits would be beneficial for patients who are under weight management care. As part of this study, participants will be asked to complete a survey to give the study team a better idea of their current health conditions and if this study will be good fit for them. Once the survey has been completed, participants will then be randomly assigned to one of two groups. Group one will include participation in shared medical visits over a period of eight weeks. In addition to the medical visits, this group will also include two cooking classes. Group two will be asked to complete online Full Living Plate modules. Participants will be asked to complete another survey at the end of the study.

Detailed description

The purpose of this study is to have participants who are undergoing weight management attend new types of medical visits called shared medical visits and provide their feedback to the research staff. The shared medical visit or group visit is a new method of care delivery at Duke University Health System where patients with similar medical conditions have an appointment as a group with a provider. Patients can decide to share with the group or share privately with the provider team. Up to 50 people will take part in this study at Duke. As part of this study, participants will be asked to complete a survey prior to starting the study to make sure that they are a good fit for the study. Participants will be randomly assigned (like the flip of a coin) to one of two groups. Those placed in group one will have 4 group visit sessions that include 2 cooking demonstrations and those placed in group two will be asked to complete online Full Plate Living Modules. Both groups will receive the medically tailored groceries and can complete both the pre-survey and post-survey. Both groups will receive similar content, although only the individuals in the first option will have the opportunity to attend in-person group visit sessions. In-person sessions will be held at the Duke Integrative Medicine Center. While on study, participants will receive medically tailored groceries delivered to their home every other week. Each delivery is about 70 servings of produce with possible additional grocery items. If participants are unable to attend one of the group sessions while they are in the study, Telehealth group visits will be offered. However, this is not an alternative to an in-person class. This is being offered and approved by the study doctor on a case-by-case basis. Participation in this study will last a total of eight weeks.

Interventions

BEHAVIORALShared Medical Visits

Shared group medical visits over eight weeks and two cooking classes.

BEHAVIORALFull Plate Living

Online modules teaching how a high-fiber diet can lead to more energy, lower cholesterol, better blood sugar, and easier weight loss.

Sponsors

Ardmore Institute of Health
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Patients actively receiving care at the Duke Lifestyle and Weight Management Center (DLWMC) 2. Patients with obesity defined by BMI ≥30 kg/m2 3. Patients must live in Durham County 4. Patients age ≥18 years 5. Patients must be willing and able to consent to participating in 4 shared medical appointments with 10-13 other DLWMC patients over the course of 8 weeks 6. DLWMC provider must medically clear their participation in this program

Exclusion criteria

1. Patients with unstable medical or mental health condition, as deemed by their DLWMC medical provider (e.g., uncontrolled eating disorder, active severe major depression, gastrointestinal disease that would preclude consumption of a high fiber diet) 2. Patients who are pregnant or plan to become pregnant will be excluded, as change in weight will be a secondary outcome and patients may have specific dietary needs not covered by the content offered by this study

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Intervention Method (AIM)0 and 12 weeksAcceptability is defined as the perception among participants that a given treatment (food is medicine intervention with either group visits or online modules) is agreeable, palatable, or satisfactory. The AIM total score ranges from 1 to 20, where a higher score indicates greater acceptability.
Intervention Appropriateness Measure (IAM)0 and 12 weeksAppropriateness is defined as the perceived fit, relevance, or compatibility of the treatment (food is medicine intervention with either group visits or online modules) for the practice setting, provider, and participant; and/or perceived fit of the innovation to address obesity. The IAM total score ranges from 1 to 20, where a higher score indicates greater appropriateness.

Secondary

MeasureTime frameDescription
Fruit and Vegetable Consumption as measured by the 10-item Dietary Screener Questionnaire (DSQ)0 and 12 weeksThe DSQ total score ranges from 0 to 100, where a higher score indicates greater fruit and vegetable consumption over the past month.
Number of participants with Nutrition Security0 and 12 weeksNutrition security is defined as consistent access, availability, and affordability of foods and beverages that promote well-being and prevent (and if needed, treat) disease.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026